Larvol Delta - SLORP-Preserve-A-24Month-Trial-of-NPI001-for-the-Preservation-of-Photoreceptors-in-Retinitis-Pigmentosa-Associated-With-Usher-Syndrome

N-acetylcysteine amide (NPI 001) - Nacuity Pharma, Arctic Therapeutics

http://clinicaltrials.gov/ct2/show/NCT07710196

Jul 18, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next